[7] Purification and Assay of cAMP, cGMP, and Cyclic Nucleotide Analogs in Cells Treated with Cyclic Nucleotide Analogs

Jackie D. Corbin, Thomas W. Gettys, Peter F. Blackmore, Stephen J. Beebe, Sharron H. Francis, David B. Glass, J. Bruce Redmon, Virender S. Sheorain, Leslie R. Landiss

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

To determine cAMP, cGMP, or cyclic nucleotide analog levels, this chapter develops a method to first separate the analog(s) from cAMP or cGMP by a simple chromatographic procedure followed by functionally directed assay of the respective cyclic nucleotide by either cAMP- or cGMP-dependent protein kinase activation. The sensitivity is much better than that of the cyclic nucleotide binding assays, and approaches that of the radioimmunoassays. Because high concentrations of cyclic nucleotide analogs are usually used for intact tissue incubations, trace cyclic nucleotide contaminants in commercial cyclic nucleotides may not be separated during purification and would thus interfere with the assay for the nucleotide of interest. It is therefore necessary to purify the analogs before use. Alternatively, sensitive and specific cAMP- and cGMP-dependent protein kinase activation assays are described in the chapter.

Original languageEnglish (US)
Pages (from-to)74-82
Number of pages9
JournalMethods in enzymology
Volume159
Issue numberC
DOIs
StatePublished - Jan 1988

Fingerprint Dive into the research topics of '[7] Purification and Assay of cAMP, cGMP, and Cyclic Nucleotide Analogs in Cells Treated with Cyclic Nucleotide Analogs'. Together they form a unique fingerprint.

  • Cite this

    Corbin, J. D., Gettys, T. W., Blackmore, P. F., Beebe, S. J., Francis, S. H., Glass, D. B., Redmon, J. B., Sheorain, V. S., & Landiss, L. R. (1988). [7] Purification and Assay of cAMP, cGMP, and Cyclic Nucleotide Analogs in Cells Treated with Cyclic Nucleotide Analogs. Methods in enzymology, 159(C), 74-82. https://doi.org/10.1016/0076-6879(88)59009-2